Health Care & Life Sciences » Biotechnology | Trillium Therapeutics Inc.

Trillium Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
648.80
658.00
457.70
4,287.40
4,709.00
3,146
Gross Income
648.80
658.00
457.70
4,287.40
4,709.00
3,146
SG&A Expense
3,770.90
12,409.10
21,330.40
29,358.90
37,572.00
41,733
EBIT
4,419.70
13,067.10
21,788.20
33,646.30
42,281.00
44,879
Unusual Expense
113.00
429.80
-
316.10
1,158.00
2,326
Non Operating Income/Expense
5.60
10.30
6,106.70
2,026.80
4,742.00
3,489
Interest Expense
40.10
77.00
84.90
82.40
68.00
43
Pretax Income
4,523.10
13,205.40
15,277.90
35,654.10
45,211.00
42,675
Income Tax
233.80
323.50
544.20
3,921.10
123.00
189
Consolidated Net Income
4,289.30
12,881.80
14,733.70
31,733.10
45,088.00
42,486
Net Income
4,289.30
12,881.80
14,733.70
31,733.10
45,088.00
42,486
Net Income After Extraordinaries
4,289.30
12,881.80
14,733.70
31,733.10
45,088.00
42,486
Net Income Available to Common
4,289.30
12,881.80
14,733.70
31,733.10
45,088.00
42,486
EPS (Basic)
3.30
3.06
2.22
4.06
4.61
3.06
Basic Shares Outstanding
1,356.90
4,202.90
6,641.20
7,820.20
9,771.00
13,906.10
EPS (Diluted)
3.16
3.06
2.22
4.06
4.61
3.06
Diluted Shares Outstanding
1,356.90
4,202.90
6,641.20
7,820.20
9,771.00
13,906.10
EBITDA
3,770.90
12,409.10
21,330.40
29,358.90
37,572.00
41,733
Non-Operating Interest Income
44.10
378.70
488.50
417.50
722.00
1,084

About Trillium Therapeutics

View Profile
Address
2488 Dunwin Drive
Mississauga Ontario L5L 1J9
Canada
Employees -
Website http://www.trilliumtherapeutics.com
Updated 07/08/2019
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of innovative therapies for the treatment of cancer. Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Toronto, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.